Brief: SMS Lifesciences India Approves Acquisition Of Mahi Drugs
23/02/2018 09:18
Feb 23 (Reuters) - SMS Lifesciences India Ltd SMSL.NS :
* SAYS APPROVED ACQUISITION OF MAHI DRUGS PRIVATE LIMITED
Source text - http://bit.ly/2F328Ut
Further company coverage: SMSL.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Haleos Labs
See all newsBrief: Haleos Labs Entered Into Strategic Development Collaboration With Hrv Global Life Sciences
SMS Lifesciences India soars; facility gets US FDA clearance
Brief: SMS Lifesciences India Gets EIR With VAI Status From USFDA
Brief: SMS Lifesciences India Dec-Quarter Consol Net Profit Rises
Brief: Sms Lifesciences India Sept-Qtr Consol Net Profit Falls